You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Oriola Q4'23: Dual Development
By Rauli Juva
Oriola's earnings growth is guided to continue this year. Revenue, and especially invoicing, increased well in comparable currencies. The joint venture is clearly in the negative. The company's CEO, Katarina Gabrielson, commented on the past quarter in an interview with analyst Rauli Juva.
More about Oriola: https://www.inderes.fi/companies/Oriola
Contents:
00:00 Start
00:15 Q4’23
01:08 Seasonality
01:38 Sweden
02:38 Investments
04:02 New warehouse
05:15 Sweden's divestment
05:56 Guidance
Aktier i Vælten - Novo Nordisk: Vi må vente på re-eksamen efter skuffende data
Introduction to the Helsinki Stock Exchange | Company Night Dec. 16, 2024
Surgical Science Sweden, Audiocast with teleconference, Press Conference, 2024
GomSpace – Management Q&A
ExpreS2ion Biotech – A look back at 2024 with CEO
View all videos